Private: 22nd Valve Disease, Structural Interventions and Diastology Summit 2020

Cleveland Clinic’s world renowned faculty congregates with several guest speakers for the 22nd Valve Disease, Structural Interventions and Diastology Summit.  This activity will focus on mitral, aortic and tricuspid valve diseases, while providing a unique opportunity for updates in new and emerging topics.  These include basic and advanced imaging techniques such as 3-D echocardiography, fusion imaging, strain imaging and interventional echo.  Worth up to 16.75 AMA PRA Category I Credits™, this enduring material meets Echo Lab CME requirements for Physicians and sonographers.  Additionally, physicians can earn up to 16.75 ABIM MOC points for this activity.

Topics/Speakers

Session 1: Valve Disease– Focus on the Mitral Valve

Complexities of the Mitral Valve: Structure and Mechanics	Robert J. Siegel, MD
Mitral Regurgitation: Etiology and Quantification	Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Management of Mitral Regurgitation	L. Leonardo Rodriguez, MD
Primary and Secondary Mitral Regurgitation: Who, Who-Not, and When to Do Surgery?	Gosta Pettersson, MD, PhD
Percutaneous Mitral Valve Repair: Imaging and Procedural Guidance	Robert J. Siegel, MD
How Does the Sonographer Acquire Quality Data for the Mitral Valve and the Left Atrium?	Amy Dillenbeck, MS, ACS, RDCS, FASE
Panel Discussion

Session 2: Structural Interventions– Mitral Valve and Left Atrium

Exercise Testing in Mitral Valve Disease: What Do the Guidelines Say?	Christine Jellis, MD, PhD
Evaluation of Valvular Regurgitation After Percutaneous Valve Repair: What Do the New Guidelines Say?	Robert J. Siegel, MD
LAA Occluder Devices – Current Indications	Robert J. Cubeddu, MD
Calcific Mitral Stenosis: Percutaneous and Surgical Options and Challenges	Samir Kapadia, MD
Panel Discussion

Session 3: Controversies in Mitral Valve Disease

Debate: Transcatheter Mitral Leaflet Repair Will Be Routinely Used to Treat Severe Functional Mitral Regurgitation	Robert J. Siegel, MD
Debate: Transcatheter Mitral Leaflet Repair Will Not Be Routinely Used to Treat Severe Functional Mitral Regurgitation	Samir Kapadia, MD
Debate: Transcatheter Mitral Leaflet Repair Pro Rebuttal	Robert J. Siegel, MD
Transcatheter Mitral Leaflet Repair Debate Discussion

Session 4: Percutaneous Mitral Valve Intervention Cases

Percutaneous Mitral Valve Case #1	Robert J. Siegel, MD
Double Trouble: A Case of Mitral Valve Disease With Two Mechanisms	Balint Laczay, MD
Percutaneous Mitral Valve Case #3	Michael Chetrit, MD
Mitraclip: The Corner Pocket	Robert J. Cubeddu, MD
Mechanisms Mechanical Valve Failure	Gosta Pettersson, MD, PhD

Session 5: Valve Disease– Focus on the Aortic Valve

Low Flow, Low Gradient Aortic Stenosis: What Does This Mean and How to Image?	Rebecca Hahn, MD
Stress Echo in Aortic Stenosis: Indications, Methods, Impact on Management	Christine Jellis, MD, PhD
Aortic Root Anatomy: Utilizing the Best of Echo and CT Imaging to Optimize TAVR Outcomes	L. Leonardo Rodriguez, MD
TAVR vs. SAVR: New Devices and Expanding Indications	Samir Kapadia, MD
Panel Discussion

Session 6: Structural Interventions and the Tricuspid Valve

The Forgotten Valve: Tricuspid Valve Therapies	Jose Navia, MD
Imaging the Tricuspid Valve for Procedural Guidance	Rebecca Hahn, MD
Percutaneous Treatment of Tricuspid Regurgitation: Which Patients and What Devices?	Samir Kapadia, MD
How Does the Sonographer Acquire Quality Data for the Tricuspid Valve and Right- Sided Chambers?	Anne Campbell, MS, RDCS
Panel Discussion

Session 7: Controversies in Aortic Valve Disease

Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Pro	Rebecca Hahn, MD
Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Con	Gosta Pettersson, MD, PhD
Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Pro	Rebecca Hahn, MD
Debate: TAVR Will Replace SAVR in Low and Moderate Risk Aortic Stenosis Patients – Con	Gosta Pettersson, MD, PhD
Panel Discussion

Session 8: Aortic Valve Intervention Cases

Aortic Valve Interventions Case #1	Robert J. Siegel, MD
Severe Tricuspid Regurgitation	Rebecca Hahn, MD
Mitral Balloon Valvuloplasty in Severe Calcific Mitral Stenosis	Robert J. Cubeddu, MD
Aortic Valve Interventions Case #4	Gosta Pettersson, MD, PhD

Session 9: Diastolic Function Evaluation

Physiology of Left Ventricular Diastolic Function: Is it Really That Complicated?	Sherif Nagueh, MD
Estimating LV Filling Pressures With Doppler Echo and Hemodynamics	Partho Sengupta, MD
How to Handle Indeterminate and Difficult Cases	Amy Dillenbeck, MS, ACS, RDCS, FASE
Diastology Guidelines: State of the Art	Sherif Nagueh, MD
Cardiac Amylodosis: What is New in 2020?	Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Panel Discussion

Session 10: Myocardial and Pericardial Diseases

How to Differentiate Athlete’s Heart From Non-obstructive Hypertrophic Cardiomyopathy – Management Pearls	Craig Asher, MD
Radiation Associated Cardiac Disease: The Role of Multimodality Imaging	Christine Jellis, MD, PhD
Complicated Pericarditis: A Paradigm Shift of Treatment	Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE, FESC
Artificial Intelligence: Is This Going to Help the Clinician?	Partho Sengupta, MD
Contrast Echo for the Assessment of Cardiac Structure and Function	Amy Dillenbeck, MS, ACS, RDCS, FASE

Session 11: Controversies in Cardiac Imaging

Debate: Strain Will Replace EF in Evaluation of Heart Disease	Partho Sengupta, MD
Debate: Strain Will Not Replace EF in Evaluation of Heart Disease	Sherif Nagueh, MD
Strain Debate: Pro Rebuttal	Partho Sengupta, MD
Strain Debate: Con Rebuttal	Sherif Nagueh, MD
Strain Debate Discussion

Session 12: Cases in Constriction, Restriction, Contrast and More

Case #1	Michael Chetrit, MD
Case #2	Sherif Nagueh, MD
Case #3: Unrepaired Tetrology of Fallot in an Adult	Jared Klein, MD, MPH
Case #4: Worsening TRA After Pericadiectomy	Ray Tabucanon, MD

Release Date: 5/15/20
CME Expiration: 5/14/22